131 related articles for article (PubMed ID: 32924814)
1. Primary Lung Cribriform Adenocarcinoma With Squamoid Morules Harboring Somatic
Wu H; Ye Q; Razzano D; Tugal O; Rosenblum J; Weigel T; Zhong M
Pediatr Dev Pathol; 2020; 23(6):472-475. PubMed ID: 32924814
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological, Radiological, and Molecular Features of Primary Lung Adenocarcinoma with Morule-Like Components.
Wang LL; Ding L; Zhao P; Guan JJ; Ji XB; Zhou XL; Shao SH; Zou YW; Fu WW; Lin DL
Dis Markers; 2021; 2021():9186056. PubMed ID: 34234879
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary metastasis of cribriform-morular variant of thyroid carcinoma mimicking primary adenocarcinoma of the lung: A potential pitfall.
Laforga JB; Pedro T; Gasent JM
Diagn Cytopathol; 2020 Jan; 48(1):78-81. PubMed ID: 31483569
[TBL] [Abstract][Full Text] [Related]
4. Morphologic, Immunohistochemical, and Genetic Differences Between High-grade and Low-grade Fetal Adenocarcinomas of the Lung.
Li Y; Xi SY; Yong JJ; Wu XY; Yang XH; Wang F
Am J Surg Pathol; 2021 Nov; 45(11):1464-1475. PubMed ID: 34138800
[TBL] [Abstract][Full Text] [Related]
5. Mesonephric-like adenocarcinoma of the ovary with squamoid morular metaplasia, aberrant β-catenin expression, and concurrent FGFR2 and CTNNB1 mutations: a case report.
Xu J; Park KJ; Rehrauer WM; Weisman PS
Virchows Arch; 2024 Jan; 484(1):147-150. PubMed ID: 36856760
[TBL] [Abstract][Full Text] [Related]
6. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules.
Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ
Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775
[TBL] [Abstract][Full Text] [Related]
7. An oncogenic CTNNB1 mutation is predictive of post-operative recurrence-free survival in an EGFR-mutant lung adenocarcinoma.
Kim Y; Ahn B; Yoon S; Lee G; Kim D; Chun SM; Kim HR; Jang SJ; Hwang HS
PLoS One; 2023; 18(6):e0287256. PubMed ID: 37347751
[TBL] [Abstract][Full Text] [Related]
8. Novel gene mutations in well-differentiated fetal adenocarcinoma of the lung in the next generation sequencing era.
Fu Y; Wu Q; Su F; Tang Y; Lin Y; Wang W; Jiang L
Lung Cancer; 2018 Oct; 124():1-5. PubMed ID: 30268445
[TBL] [Abstract][Full Text] [Related]
9. Next generation sequencing of lung adenocarcinoma subtypes with intestinal differentiation reveals distinct molecular signatures associated with histomorphology and therapeutic options.
Jurmeister P; Vollbrecht C; Behnke A; Frost N; Arnold A; Treue D; Rückert JC; Neudecker J; Schweizer L; Klauschen F; Horst D; Hummel M; Dietel M; von Laffert M
Lung Cancer; 2019 Dec; 138():43-51. PubMed ID: 31634654
[TBL] [Abstract][Full Text] [Related]
10. Morules and morule-like features associated with carcinomas in various organs: report with immunohistochemical and molecular studies.
Makishi S; Kinjo T; Sawada S; Chinen K; Hirayasu T; Hamada T; Saito K; Iwamasa T
J Clin Pathol; 2006 Jan; 59(1):95-100. PubMed ID: 16394288
[TBL] [Abstract][Full Text] [Related]
11. High Prevalence of EGFR Mutations in Lung Adenocarcinomas From Brazilian Patients Harboring the TP53 p.R337H Variant.
Barbosa MVR; Cordeiro de Lima VC; Formiga MN; Andrade de Paula CA; Torrezan GT; Carraro DM
Clin Lung Cancer; 2020 Mar; 21(2):e37-e44. PubMed ID: 31889631
[No Abstract] [Full Text] [Related]
12. ARID1A Gene Driver Mutations in Lung Adenocarcinomas.
Karachaliou N; Paulina Bracht JW; Rosell R
J Thorac Oncol; 2018 Dec; 13(12):e255-e257. PubMed ID: 30467048
[No Abstract] [Full Text] [Related]
13. CDK1 serves as a potential prognostic biomarker and target for lung cancer.
Li M; He F; Zhang Z; Xiang Z; Hu D
J Int Med Res; 2020 Feb; 48(2):300060519897508. PubMed ID: 32020821
[TBL] [Abstract][Full Text] [Related]
14. Histopathological and molecular study for synchronous lung adenocarcinoma staging.
Donfrancesco E; Yvorel V; Casteillo F; Stachowicz ML; Patoir A; Tiffet O; Péoc'h M; Forest F
Virchows Arch; 2020 Jun; 476(6):835-842. PubMed ID: 31900636
[TBL] [Abstract][Full Text] [Related]
15. Frequent nuclear β-catenin expression in pulmonary enteric-type adenocarcinoma according to the current World Health Organization criteria.
Kishikawa S; Hayashi T; Takamochi K; Ura A; Sasahara N; Saito T; Suzuki K; Yao T;
Virchows Arch; 2023 Nov; 483(5):699-703. PubMed ID: 37740071
[TBL] [Abstract][Full Text] [Related]
16. Untangling the evolutionary roots of lung cancer.
Devarakonda S; Govindan R
Nat Commun; 2019 Jul; 10(1):2979. PubMed ID: 31278259
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor mutation status in pulmonary adenocarcinoma: Multi-institutional data discussion at national conference of "Lung Cancer Management in Indian context".
Nakra T; Mehta A; Bal A; Nambirajan A; Mishra D; Midha D; Gupta N; Arora N; Gupta P; Gupta P; Singh V; Jain D
Curr Probl Cancer; 2020 Jun; 44(3):100561. PubMed ID: 32169258
[TBL] [Abstract][Full Text] [Related]
18. Two Cases of Sinonasal Non-Intestinal-Type Adenocarcinoma with Squamoid Morules Expressing Nuclear
Villatoro TM; Mardekian SK
Case Rep Pathol; 2018; 2018():8741017. PubMed ID: 30302299
[TBL] [Abstract][Full Text] [Related]
19. Adenocarcinoma in situ in type I congenital pulmonary airway malformation.
Santosham R; Santosham R; Tirunagari V; Jacob SS
Asian Cardiovasc Thorac Ann; 2019 Sep; 27(7):606-608. PubMed ID: 31226882
[No Abstract] [Full Text] [Related]
20. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
Fan J; Dai X; Wang Z; Huang B; Shi H; Luo D; Zhang J; Cai W; Nie X; Hirsch FR
Clin Lung Cancer; 2019 Jul; 20(4):e517-e530. PubMed ID: 31138506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
